神経調節の世界市場予測(~2025年)

MarketsandMarketsが発行した調査報告書(BT 3571)
◆英語タイトル:Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) - Global Forecast to 2025
◆商品コード:BT 3571
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年2月28日
◆ページ数:157
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarkets社は神経調節の世界市場が、2020年58億ドルから2025年88億ドルまで、年平均8.6%成長すると予測しています。本調査レポートでは、神経調節の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、技術別(内部神経調節、外部神経調節)分析、用途別(虚血、慢性疼痛、パーキンソン病、うつ病、振戦、てんかん、片頭痛)分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・神経調節の世界市場:技術別(内部神経調節、外部神経調節)
・神経調節の世界市場:用途別(虚血、慢性疼痛、パーキンソン病、うつ病、振戦、てんかん、片頭痛)
・神経調節の世界市場:地域別
・競争状況
・企業概要
【レポートの概要】

“The neuromodulation market is projected to grow at a CAGR of 8.6% during the forecast period (2020–2025).”
The global neuromodulation market size is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by factors such as the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, will challenge market growth.

“By technology, the internal neuromodulation segment is expected to grow at the highest CAGR during the forecast period.”
Based on technology, the neuromodulation market is segmented into internal neuromodulation and external neuromodulation. The internal neuromodulation segment accounted for the largest market share in 2019. This segment is also expected to register the highest growth during the forecast period. This growth in this segment is driven primarily by reductions in post-surgical complications and length of hospital stay, as well as long-term cost savings associated with the use of internal neuromodulation devices.

“By type, the transcutaneous electrical nerve stimulation (TENS) segment dominated the external neuromodulation market in 2019.”
Based on type, the external neuromodulation market is segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES). TENS accounted for the largest share of the external neuromodulation market in 2019, owing to the higher incidence of chronic disorders, the wide range of applications of these devices, their cost-effectiveness, and the rising demand for non-invasive therapy.

“Asia Pacific neuromodulation market is expected to witness the highest growth during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the high incidence of neurological disorders, increasing public and private investments, and ongoing research.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–36%, Tier 2–45%, and Tier 3–19%
• By Designation: C-level–33%, Director-level–40%, and Others–27%
• By Region: North America–36%, Europe–28%, Asia Pacific–19%, RoW-17%

The prominent players operating in the global neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel).

Research Coverage:
The report analyzes the neuromodulation market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the neuromodulation market
• Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the neuromodulation market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global neuromodulation market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the neuromodulation market

【レポートの目次】

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 24)
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 31)

4 Premium Insights (Page No. – 34)
4.1 Neuromodulation: Market Overview
4.2 North America: Neuromodulation Market, By Technology (2019)
4.3 Global Spinal Cord Stimulation Market, By Application

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Neurological Disorders
5.2.1.2 Research Into Expanding the Applications of Neuromodulation
5.2.1.3 Rising Awareness on Neurodegenerative Disorders
5.2.2 Restraints
5.2.2.1 High Cost of Neuromodulation Procedures
5.2.3 Opportunities
5.2.3.1 Expansion in Emerging Economies
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals

6 Neuromodulation Market, By Technology (Page No. – 41)
6.1 Introduction
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation
6.2.1.1 Rising Incidence of Indications and Efficacy & Reversibility of Procedure Have Supported the Adoption of Scs
6.2.2 Deep Brain Stimulation
6.2.2.1 Increasing Research has Driven the Development of Advanced Dbs Systems
6.2.3 Vagus Nerve Stimulation
6.2.3.1 Rising Disorder Incidence and Growing Geriatric Population are Driving Market Growth
6.2.4 Sacral Nerve Stimulation
6.2.4.1 Effectiveness of Sns and Rising Incidence of Urological Disorders are the Key Growth Drivers for This Market
6.2.5 Gastric Electrical Stimulation
6.2.5.1 Ges is Mainly Used for the Treatment of Gerd and Gastroparesis
6.3 External Neuromodulation
6.3.1 Transcutaneous Electrical Nerve Stimulation
6.3.1.1 Extensive Use in Healthcare, Low Cost, and Ease of Use Will Favor Market Growth
6.3.2 Transcranial Magnetic Stimulation
6.3.2.1 Minimal Patient Discomfort Associated With Tms has Supported the Demand for the Technology
6.3.3 Respiratory Electrical Stimulation
6.3.3.1 Increasing Incidence of Spinal Cord Injuries and High Treatment Efficacy Have Driven Market Growth

7 Neuromodulation Market, By Application (Page No. – 66)
7.1 Introduction
7.2 Spinal Cord Stimulation, By Application
7.2.1 Chronic Pain
7.2.1.1 High Incidence of Chronic Pain Supports Market Growth
7.2.2 Failed Back Surgery Syndrome
7.2.2.1 Rising Incidence of Fbss has Driven Demand for Stimulation Technologies
7.2.3 Ischemia
7.2.3.1 High Incidence of Ischemia and Effectiveness of Neuromodulation Supports the Growth of the Market
7.3 Deep Brain Stimulation, By Application
7.3.1 Parkinson’s Disease
7.3.1.1 Rising Incidence of Parkinson’s Disease and Growing R&D Activity in This Area are Likely to Drive Market Growth
7.3.2 Tremors
7.3.2.1 High Efficacy of Dbs in Treating Tremors has Boosted Demand for the Technology
7.3.3 Depression
7.3.3.1 Use of Dbs in Depression Treatment is Restrained By A Lack of Evidence for Its Efficacy
7.3.4 Other Dbs Applications
7.4 Sacral Nerve Stimulation Market, By Application
7.4.1 Urinary Incontinence
7.4.1.1 High Incidence of Urinary Incontinence Offers Growth Opportunities
7.4.2 Fecal Incontinence
7.4.2.1 High Reductions in Symptom Recurrence Have Supported the Use of Sns in Fecal Incontinence Treatment
7.5 Vagus Nerve Stimulation, By Application
7.5.1 Epilepsy
7.5.1.1 Advantages Associated With Vns in the Treatment of Epilepsy are Expected to Drive the Market
7.5.2 Other Vns Applications
7.6 Gastric Electrical Stimulation, By Application
7.6.1 Gastroparesis
7.6.1.1 Ges Treatment Reduces Hospital Stay Duration for Patients Affected By Gastroparesis
7.6.2 Obesity
7.6.2.1 High Prevalence of Obesity and Benefits of Ges are Likely to Drive the Market
7.7 Transcutaneous Electrical Nerve Stimulation, By Application
7.7.1 Treatment-Resistant Depression
7.7.1.1 High Prevalence of Depression is Driving Market Growth
7.7.2 Other Tens Applications
7.8 Transcranial Magnetic Stimulation, By Application
7.8.1 Depression
7.8.1.1 Effectiveness of This Treatment Method and Its Increased Acceptance Among Patients are Driving Demand
7.8.2 Migraine
7.8.2.1 High Prevalence of Migraine is Expected to Increase the Demand for Transcranial Magnetic Stimulation
7.9 Respiratory Electrical Stimulation, By Application
7.9.1 Spinal Cord Injury
7.9.1.1 High Prevalence of Spinal Cord Injury is Likely to Drive Market Growth in the Future

8 Neuromodulation Market, By Region (Page No. – 81)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 Rising Prevalence of Chronic Diseases is Expected to Increase the Demand for Neuromodulation Devices in the US
8.2.2 Canada
8.2.2.1 Rising Healthcare Expenditure and Increasing Disease Prevalence Will Drive Demand for Neurostimulation
8.3 Europe
8.3.1 Germany
8.3.1.1 High Healthcare Expenditure and Favorable Government Initiatives Have Ensured Strong Market Growth in Germany
8.3.2 UK
8.3.2.1 High Investment By Public and Private Sectors Play an Important Role in the Growth of the Neuromodulation Market in the UK
8.3.3 France
8.3.3.1 Availability of Insurance and Favorable Healthcare Reforms Have Contributed to the Growth of the French Market
8.3.4 Italy
8.3.4.1 Easy Access to Healthcare Services has Supported the Use of Neuromodulation in Italy
8.3.5 Spain
8.3.5.1 The Growth of This Market Can Be Attributed to the Increasing Incidences of Chronic Diseases
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Japan Dominates the APAC Market for Neuromodulation
8.4.2 China
8.4.2.1 Infrastructural Development, Aging Population, and Rising Disease Incidence Will Favor Market Growth in China
8.4.3 India
8.4.3.1 Improvements in Healthcare Infrastructure in the Country Will Support the Growth of the Neuromodulation Market
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.1.1 Latin America Holds the Largest Share of the Neuromodulation Market in the Row
8.5.2 Middle East & Africa
8.5.2.1 The High Cost of Neuromodulation Will Hamper Market Growth in the Region

9 Competitive Landscape (Page No. – 117)
9.1 Overview
9.2 Market Share Analysis, 2019
9.3 Competitive Scenario
9.4 Competitive Leadership Mapping (Overall Market) (2019)
9.4.1 Visionary Leaders
9.4.2 Innovators
9.4.3 Dynamic Differentiators
9.4.4 Emerging Companies

10 Company Profiles (Page No. – 123)
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 Medtronic
10.2 Boston Scientific Corporation
10.3 Abbott
10.4 Livanova
10.5 Nevro Corporation
10.6 Neurosigma, Inc.
10.7 Neuropace, Inc.
10.8 Biocontrol Medical
10.9 Synapse Biomedical
10.10 Neuronetics
10.11 Bioness
10.12 Soterix Medical
10.13 Integer Holdings Corporation
10.14 Bioinduction
10.15 Other Players
10.15.1 Gimer Medical
10.15.2 GTX Medical
10.15.3 Helius Medical Technologies
10.15.4 Microtransponder
10.15.5 Neuronano
10.15.6 Bluewind Medical
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. – 148)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details

List of Tables (177 Tables)

Table 1 Indicative List: Neuromodulation Clinical Trials
Table 2 Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 3 Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 4 Internal Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 5 North America: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 6 Europe: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 7 APAC: Internal Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 8 RoW: Internal Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 9 Spinal Cord Stimulation Market, By Region, 2018–2025 (USD Million)
Table 10 Spinal Cord Stimulation Market, By Region, 2018–2025 (Units)
Table 11 North America: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 12 Europe: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 13 APAC: Spinal Cord Stimulation Market, By Country, 2018–2025 (USD Million)
Table 14 RoW: Spinal Cord Stimulation Market, By Region, 2018–2025 (USD Million)
Table 15 Deep Brain Stimulation Market, By Region, 2018–2025 (USD Million)
Table 16 Deep Brain Stimulation Market, By Region, 2018–2025 (Units)
Table 17 North America: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 18 Europe: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 19 APAC: Deep Brain Stimulation Market, By Country, 2018–2025 (USD Million)
Table 20 RoW: Deep Brain Stimulation Market, By Region, 2018–2025 (USD Million)
Table 21 Vagus Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 22 Vagus Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 23 North America: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 24 Europe: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 25 APAC: Vagus Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 26 RoW: Vagus Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 27 Sacral Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 28 Sacral Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 29 North America: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 30 Europe: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 31 APAC: Sacral Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 32 RoW: Sacral Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 33 Gastric Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 34 Gastric Electrical Stimulation Market, By Region, 2018–2025 (Units)
Table 35 North America: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 36 Europe: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 37 APAC: Gastric Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 38 RoW: Gastric Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 39 External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 40 External Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 41 North America: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 42 Europe: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 43 APAC: External Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 44 RoW: External Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 45 Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 46 Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (Units)
Table 47 North America: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 48 Europe: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 49 APAC: Transcutaneous Electrical Nerve Stimulation Market, By Country, 2018–2025 (USD Million)
Table 50 RoW: Transcutaneous Electrical Nerve Stimulation Market, By Region, 2018–2025 (USD Million)
Table 51 Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (USD Million)
Table 52 Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (Units)
Table 53 North America: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 54 Europe: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 55 APAC: Transcranial Magnetic Stimulation Market, By Country, 2018–2025 (USD Million)
Table 56 RoW: Transcranial Magnetic Stimulation Market, By Region, 2018–2025 (USD Million)
Table 57 Respiratory Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 58 Respiratory Electrical Stimulation Market, By Region, 2018–2025 (Units)
Table 59 North America: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 60 Europe: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 61 APAC: Respiratory Electrical Stimulation Market, By Country, 2018–2025 (USD Million)
Table 62 RoW: Respiratory Electrical Stimulation Market, By Region, 2018–2025 (USD Million)
Table 63 Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 64 Spinal Cord Stimulation Market for Chronic Pain, By Region, 2018–2025 (USD Million)
Table 65 Spinal Cord Stimulation Market for Failed Back Surgery Syndrome,By Region, 2018–2025 (USD Million)
Table 66 Spinal Cord Stimulation Market for Ischemia, By Region, 2018–2025 (USD Million)
Table 67 Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 68 Deep Brain Stimulation Market for Parkinson’s Disease, By Region, 2018–2025 (USD Million)
Table 69 Deep Brain Stimulation Market for Tremors, By Region, 2018–2025 (USD Million)
Table 70 Deep Brain Stimulation Market for Depression, By Region, 2018–2025 (USD Million)
Table 71 Deep Brain Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 72 Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 73 Sacral Nerve Stimulation Market for Urinary Incontinence, By Region, 2018–2025 (USD Million)
Table 74 Sacral Nerve Stimulation Market for Fecal Incontinence, By Region, 2018–2025 (USD Million)
Table 75 Vagus Nerve Market, By Application, 2018–2025 (USD Million)
Table 76 Vagus Nerve Stimulation Market for Epilepsy, By Region, 2018–2025 (USD Million)
Table 77 Vagus Nerve Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 78 Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 79 Gastric Electrical Stimulation Market for Gastroparesis, By Region, 2018–2025 (USD Million)
Table 80 Gastric Electrical Stimulation Market for Obesity, By Region, 2018–2025 (USD Million)
Table 81 Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 82 Transcutaneous Electrical Nerve Stimulation Market for Treatment-Resistant Depression, By Region, 2018–2025 (USD Million)
Table 83 Transcutaneous Electrical Nerve Stimulation Market for Other Applications, By Region, 2018–2025 (USD Million)
Table 84 Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 85 Transcranial Magnetic Stimulation Market for Depression, By Region, 2018–2025 (USD Million)
Table 86 Transcranial Magnetic Stimulation Market for Migraine, By Region, 2018–2025 (USD Million)
Table 87 Respiratory Electrical Stimulation Market for Spinal Cord Injury, By Region, 2018–2025 (USD Million)
Table 88 Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 89 North America: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 90 North America: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 91 North America: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 92 North America: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 93 North America: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 94 North America: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 95 North America: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 96 North America: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 97 North America: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 98 North America: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 99 North America: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 100 US: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 101 US: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 102 US: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 103 Canada: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 104 Canada: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 105 Canada: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 106 Europe: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 107 Europe: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 108 Europe: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 109 Europe: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 110 Europe: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 111 Europe: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 112 Europe: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 113 Europe: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 114 Europe: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 115 Europe: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 116 Europe: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 117 Germany: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 118 Germany: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 119 Germany: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 120 UK: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 121 UK: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 122 UK: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 123 France: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 124 France: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 125 France: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 126 Italy: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 127 Italy: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 128 Italy: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 129 Spain: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 130 Spain: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 131 Spain: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 132 RoE: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 133 RoE: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 134 RoE: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 135 Asia Pacific: Neuromodulation Market, By Country, 2018–2025 (USD Million)
Table 136 Asia Pacific: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 137 Asia Pacific: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 138 Asia Pacific: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 139 Asia Pacific: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 140 Asia Pacific: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 141 Asia Pacific: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 142 Asia Pacific: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 143 Asia Pacific: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 144 Asia Pacific: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 145 Asia Pacific: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 146 Japan: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 147 Japan: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 148 Japan: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 149 China: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 150 China: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 151 China: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 152 India: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 153 India: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 154 India: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 155 RoAPAC: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 156 RoAPAC: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 157 RoAPAC: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 158 RoW: Neuromodulation Market, By Region, 2018–2025 (USD Million)
Table 159 RoW: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 160 RoW: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 161 RoW: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 162 RoW: Spinal Cord Stimulation Market, By Application, 2018–2025 (USD Million)
Table 163 RoW: Deep Brain Stimulation Market, By Application, 2018–2025 (USD Million)
Table 164 RoW: Sacral Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 165 RoW: Vagus Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 166 RoW: Gastric Electrical Stimulation Market, By Application, 2018–2025 (USD Million)
Table 167 RoW: Transcranial Magnetic Stimulation Market, By Application, 2018–2025 (USD Million)
Table 168 RoW: Transcutaneous Electrical Nerve Stimulation Market, By Application, 2018–2025 (USD Million)
Table 169 Latin America: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 170 Latin America: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 171 Latin America: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 172 MEA: Neuromodulation Market, By Technology, 2018–2025 (USD Million)
Table 173 MEA: Internal Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 174 MEA: External Neuromodulation Market, By Type, 2018–2025 (USD Million)
Table 175 Agreements and Partnerships (2017–2020)
Table 176 Acquisitions (2017–2020)
Table 177 Product Launches and Approvals (2017–2020)

List of Figures (25 Figures)

Figure 1 Neuromodulation Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Neuromodulation Market, By Technology, 2020–2025
Figure 8 Internal Neuromodulation Market, By Type, 2020–2025
Figure 9 External Neuromodulation Market, By Type, 2020–2025
Figure 10 Neuromodulation Market: Geographic Snapshot
Figure 11 Rising Prevalence of Neurological Disorders Will Drive the Growth of the Neuromodulation Market
Figure 12 Internal Neuromodulation Accounted for the Largest Share of the North American Market in 2019
Figure 13 Chronic Pain Accounts for the Largest Share of the Market During the Forecast Period
Figure 14 Neuromodulation Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 North America: Neuromodulation Market Snapshot
Figure 16 Asia Pacific: Neuromodulation Market Snapshot
Figure 17 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2017 and 2020
Figure 18 Market Ranking of Key Players, 2019
Figure 19 Competitive Leadership Mapping: Neuromodulation Market
Figure 20 Medtronic: Company Snapshot
Figure 21 Boston Scientific Corporation: Company Snapshot
Figure 22 Abbott: Company Snapshot
Figure 23 Livanova: Company Snapshot
Figure 24 Nevro Corporation: Company Snapshot
Figure 25 Integer Holdings Corporation: Company Snapshot



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経調節の世界市場予測(~2025年)(Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) - Global Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆